Sign In
Buy ACOR
$0.661
+0 (+0%)
At Close: Jul 10, 2024
Axsome's AXS-07 Meets Co-Primary Goals in Migraine Study
04:37pm, Tuesday, 07'th Apr 2020
Axsome's (AXSM) AXS-07 achieves both regulatory co-primary endpoints in the phase III INTERCEPT study for the early treatment of migraine.
Axsome's AXS-07 Meets Co-Primary Goals in Migraine Study
04:37pm, Tuesday, 07'th Apr 2020
Axsome's (AXSM) AXS-07 achieves both regulatory co-primary endpoints in the phase III INTERCEPT study for the early treatment of migraine.
Mallinckrodt Starts Rolling BLA Filing for StrataGraft Tissue
03:14pm, Tuesday, 07'th Apr 2020
Mallinckrodt (MNK) begins rolling submission of BLA for StrataGraft regenerative skin tissue therapy to the FDA for addressing adult patients with deep partial-thickness thermal burns. Stock rises.
Mallinckrodt Starts Rolling BLA Filing for StrataGraft Tissue
03:14pm, Tuesday, 07'th Apr 2020
Mallinckrodt (MNK) begins rolling submission of BLA for StrataGraft regenerative skin tissue therapy to the FDA for addressing adult patients with deep partial-thickness thermal burns. Stock rises.
